B L Chenard - JoVE Visualize

Showing results (1-10 of 12) with videos related to

Pageof 2

Sort By:

Current Pharmaceutical Design|April 24, 1999

Antagonists selective for NMDA receptors containing the NR2B subunitB L Chenard, F S Menniti

The Journal of Pharmacology and Experimental Therapeutics|February 1, 1992

Neuroprotective effects of the N-methyl-D-aspartate receptor antagonists ifenprodil and SL-82,0715 on hippocampal cells in cultureI A Shalaby, B L Chenard, M A Prochniak, et al.

Bioorganic & Medicinal Chemistry Letters|June 24, 2000

Methaqualone derivatives are potent noncompetitive AMPA receptor antagonistsB L Chenard, F S Menniti, M J Pagnozzi, et al.

Neuropharmacology|April 13, 2000

CP-101,606, an NR2B subunit selective NMDA receptor antagonist, inhibits NMDA and injury induced c-fos expression and cortical spreading depression in rodentsF S Menniti, M J Pagnozzi, P Butler, et al.

Journal of Medicinal Chemistry|May 18, 2001

Quinazolin-4-one alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists: structure-activity relationship of the C-2 side chain tetherB L Chenard, W M Welch, J F Blake, et al.

Journal of Medicinal Chemistry|October 1, 1991

Separation of alpha 1 adrenergic and N-methyl-D-aspartate antagonist activity in a series of ifenprodil compoundsB L Chenard, I A Shalaby, B K Koe, et al.

Neuropharmacology|January 24, 2002

Functional characterization of CP-465,022, a selective, noncompetitive AMPA receptor antagonistJ T Lazzaro, A V Paternain, J Lerma, et al.

Journal of Medicinal Chemistry|March 1, 1990

A unified approach to systematic isosteric substitution for acidic groups and application to NMDA antagonists related to 2-amino-7-phosphonoheptanoateB L Chenard, C A Lipinski, B W Dominy, et al.

Journal of Medicinal Chemistry|August 4, 1995

(1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: a potent new neuroprotectant which blocks N-methyl-D-aspartate responsesB L Chenard, J Bordner, T W Butler, et al.

Molecular Pharmacology|November 28, 2000

Characterization of the binding site for a novel class of noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonistsF S Menniti, B L Chenard, M B Collins, et al.

Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:

Pageof 2

Current Pharmaceutical Design|April 24, 1999

Antagonists selective for NMDA receptors containing the NR2B subunitB L Chenard, F S Menniti

The Journal of Pharmacology and Experimental Therapeutics|February 1, 1992

Neuroprotective effects of the N-methyl-D-aspartate receptor antagonists ifenprodil and SL-82,0715 on hippocampal cells in cultureI A Shalaby, B L Chenard, M A Prochniak, et al.

Bioorganic & Medicinal Chemistry Letters|June 24, 2000

Methaqualone derivatives are potent noncompetitive AMPA receptor antagonistsB L Chenard, F S Menniti, M J Pagnozzi, et al.

Neuropharmacology|April 13, 2000

CP-101,606, an NR2B subunit selective NMDA receptor antagonist, inhibits NMDA and injury induced c-fos expression and cortical spreading depression in rodentsF S Menniti, M J Pagnozzi, P Butler, et al.

Journal of Medicinal Chemistry|May 18, 2001

Quinazolin-4-one alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists: structure-activity relationship of the C-2 side chain tetherB L Chenard, W M Welch, J F Blake, et al.

Journal of Medicinal Chemistry|October 1, 1991

Separation of alpha 1 adrenergic and N-methyl-D-aspartate antagonist activity in a series of ifenprodil compoundsB L Chenard, I A Shalaby, B K Koe, et al.

Neuropharmacology|January 24, 2002

Functional characterization of CP-465,022, a selective, noncompetitive AMPA receptor antagonistJ T Lazzaro, A V Paternain, J Lerma, et al.

Journal of Medicinal Chemistry|March 1, 1990

A unified approach to systematic isosteric substitution for acidic groups and application to NMDA antagonists related to 2-amino-7-phosphonoheptanoateB L Chenard, C A Lipinski, B W Dominy, et al.

Journal of Medicinal Chemistry|August 4, 1995

(1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: a potent new neuroprotectant which blocks N-methyl-D-aspartate responsesB L Chenard, J Bordner, T W Butler, et al.

Molecular Pharmacology|November 28, 2000

Characterization of the binding site for a novel class of noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonistsF S Menniti, B L Chenard, M B Collins, et al.

Pageof 2